ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.450
Day Range
$0.440 – $0.460
52 Week Range
$0.175 – $0.630
Volume
123.96K
Avg Volume (10D)
225.25K
Market Cap
$133.16M
Price Chart
Market Statistics
Open$0.455
Previous Close$0.450
Day High$0.460
Day Low$0.440
52 Week High$0.630
52 Week Low$0.175
Valuation
Market Cap133.16M
Shares Outstanding295.92M
Price to Book16.92
Trading Activity
Volume123.96K
Value Traded55.86K
Bid$0.430 × 12,500
Ask$0.455 × 13,717
Performance
1 Day1.12%
5 Day16.88%
13 Week28.57%
52 Week125.00%
YTD4.65%
Technical Indicators
RSI (14)61.08
50-Day SMA$0.398
200-Day SMA$0.412
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.